ACQUISITIONS - Schedule of Purchase Price Allocation (Details) - USD ($) $ in Thousands	Aug. 31, 2024	Jun. 11, 2024	Jun. 16, 2023	Aug. 31, 2025
Fair value of liabilities assumed:
Goodwill	$ 96,078			$ 43,717
Immunetrics
Business Combination [Line Items]
Base merger consideration			$ 12,000
Fair value of earnout			4,100
Cash on hand			1,247
Net working capital adjustment			(377)
Adjustment to purchase price for closing indebtedness			(122)
D&O tail insurance			(7)
Bonus compensation to Immunetrics staff			(1,586)
Total purchase price			15,255
Fair value of identifiable assets acquired:
Cash			1,132
Accounts receivable			511
Security deposit			12
ROU asset			227
Deferred tax assets			799
Definite-lived intangible assets acquired			4,890
Assets acquired			9,371
Fair value of liabilities assumed:
Deferred revenue			60
Lease liability			227
Selling shareholders' D&O tail insurance responsibility			7
Business combination, liabilities assumed			294
Fair value of identifiable assets acquired and liabilities assumed			9,077
Goodwill			6,178
Immunetrics | Trade names
Fair value of identifiable assets acquired:
Indefinite-lived intangible assets acquired			1,800
Immunetrics | Customer relationships
Fair value of identifiable assets acquired:
Definite-lived intangible assets acquired			3,780
Immunetrics | Developed technology
Fair value of identifiable assets acquired:
Definite-lived intangible assets acquired			1,080
Immunetrics | Non-competes
Fair value of identifiable assets acquired:
Definite-lived intangible assets acquired			$ 30
Pro-Ficiency
Business Combination [Line Items]
Base merger consideration	100,000	$ 100,000
Net working capital adjustment	(85)	(85)
Excess cash adjustment	1,731	1,958
Measurement Period Adjustments, Excess Cash Adjustment		227
Adjustment to purchase price for closing indebtedness	(1,484)	(1,484)
Total purchase price	100,162	100,389
Measurement Period Adjustments, Total Purchase Price		227
Fair value of identifiable assets acquired:
Cash	2,513	2,513
Accounts receivable	2,064	2,064
Prepaids and other current assets	1,807	1,807
ROU asset	212	212
Other non-current assets	17	17
Definite-lived intangible assets acquired		19,010
Assets acquired	34,023	34,023
Fair value of liabilities assumed:
Accounts payable	935	935
Payroll and other current liabilities	2,302	2,302
Deferred revenue	1,456	1,456
Lease liability	212	212
Deferred tax liabilities	4,811	3,855
Measurement Period Adjustments, Deferred Tax Liabilities		(956)
Other liabilities	1,124	1,124
Business combination, liabilities assumed	10,840	9,884
Measurement Period Adjustments, Fair Value of Liabilities Assumed		(956)
Fair value of identifiable assets acquired and liabilities assumed	23,183	24,139
Goodwill	76,979	76,250
Pro-Ficiency | Trade names
Fair value of identifiable assets acquired:
Indefinite-lived intangible assets acquired	8,400	8,400
Pro-Ficiency | Customer relationships
Fair value of identifiable assets acquired:
Indefinite-lived intangible assets acquired	2,310	2,310
Definite-lived intangible assets acquired		2,310
Pro-Ficiency | Developed technology
Fair value of identifiable assets acquired:
Indefinite-lived intangible assets acquired	16,630	16,630
Definite-lived intangible assets acquired		16,630
Pro-Ficiency | Non-competes
Fair value of identifiable assets acquired:
Indefinite-lived intangible assets acquired	$ 70	70
Definite-lived intangible assets acquired		$ 70